SAN DIEGO--(BUSINESS WIRE)--Metabasis Therapeutics (NASDAQ:MBRX), a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of metabolic and liver diseases by targeting the liver and liver pathways, announced today that Dr. Paul Laikind, president and chief executive officer of Metabasis will present at the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel in San Francisco, CA. Dr. Laikind is scheduled to present on Wednesday, September 19, 2007 at 1:00 p.m. Pacific Time, and is expected to provide an overview of the Company and its product candidates. The Company’s presentation will be webcast.
